ArticleClinical and experimental medicine2026

MUC1/CA15-3 identifies a clear cell renal carcinoma characterized by Sunitinib response with a specific metabolic signature.

Giuseppe Lucarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.